We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FNHC
2301
DELISTED
FedNat Holding Company Common Stock
FNHC
| $630K | ﹤0.01% |
33,680
+14,849
| +79% | +$282K |
2016 Q2
1 quarter
|
|
|
MSGN
2302
DELISTED
MSG Networks Inc.
MSGN
| $628K | ﹤0.01% |
33,751
+10,449
| +45% | +$177K |
2016 Q2
1 quarter
|
|
2303
Prothena Corp
PRTA
$424M
| $626K | ﹤0.01% |
10,440
+4,872
| +88% | +$261K |
2016 Q2
1 quarter
|
|
2304
Embotelladora Andina Series B
AKO.B
$4.73B
| $622K | ﹤0.01% |
27,506
-27,506
| -50% | -$623K |
2016 Q2
1 quarter
|
|
2305
DELISTED
Media General, Inc
MEG
| $621K | ﹤0.01% |
33,694
+10,724
| +47% | +$190K |
2016 Q2
1 quarter
|
|
2306
Greif
GEF
$4.73B
| $619K | ﹤0.01% |
12,480
-344,162
| -97% | -$14.7M |
2016 Q2
1 quarter
|
|
2307
W.P. Carey
WPC
$14.7B
| $618K | ﹤0.01% |
9,785
+2,698
| +38% | +$180K |
2016 Q2
1 quarter
|
|
2308
CPI Aerostructures
CVU
$63.6M
| $614K | ﹤0.01% |
89,516
-10,000
| -10% | -$66.7K |
2016 Q2
1 quarter
|
|
2309
Pitney Bowes
PBI
$2.4B
| $613K | ﹤0.01% |
33,793
-99,167
| -75% | -$1.82M |
2016 Q2
1 quarter
|
|
2310
Texas Roadhouse
TXRH
$11.3B
| $611K | ﹤0.01% |
15,638
-35,135
| -69% | -$1.57M |
2016 Q2
1 quarter
|
|
|
XENT
2311
DELISTED
Intersect ENT, Inc
XENT
| $610K | ﹤0.01% |
38,516
-4,213
| -10% | -$63.4K |
2016 Q2
1 quarter
|
|
2312
Uniti Group
UNIT
$1.26B
| $609K | ﹤0.01% |
19,405
-5,618
| -22% | -$172K |
2016 Q2
1 quarter
|
|
|
JMBA
2313
DELISTED
Jamba, Inc.
JMBA
| $608K | ﹤0.01% |
55,635
-83,212
| -60% | -$896K |
2016 Q2
1 quarter
|
|
|
NW.PRC.CL
2314
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $608K | ﹤0.01% |
23,648
+20,000
| +548% | +$522K |
2016 Q2
1 quarter
|
|
2315
Alkermes
ALKS
$7.41B
| $606K | ﹤0.01% |
12,881
-6,197
| -32% | -$295K |
2016 Q2
1 quarter
|
|
|
MEET
2316
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $606K | ﹤0.01% |
97,842
-179,424
| -65% | -$1.1M |
2016 Q2
1 quarter
|
|
2317
Omnicell
OMCL
$1.69B
| $604K | ﹤0.01% |
15,766
-12,745
| -45% | -$475K |
2016 Q2
1 quarter
|
|
2318
Primerica
PRI
$8.79B
| $601K | ﹤0.01% |
11,336
+1,264
| +13% | +$69.8K |
2016 Q2
1 quarter
|
|
2319
Modine Manufacturing
MOD
$7.18B
| $600K | ﹤0.01% |
50,580
-50,281
| -50% | -$523K |
2016 Q2
1 quarter
|
|
|
TSC
2320
DELISTED
TriState Capital Holdings, Inc.
TSC
| $600K | ﹤0.01% |
37,114
-6,858
| -16% | -$102K |
2016 Q2
1 quarter
|
|
|
SIRE
2321
DELISTED
Sisecam Resources LP
SIRE
| $599K | ﹤0.01% |
19,222
+2,569
| +15% | +$77.4K |
2016 Q2
1 quarter
|
|
2322
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $596K | ﹤0.01% |
+17,059
| New | +$714K |
2016 Q3
0 quarters
|
|
|
RSTI
2323
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $595K | ﹤0.01% |
+18,484
| New | +$592K |
2016 Q3
0 quarters
|
|
|
TRHC
2324
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $592K | ﹤0.01% |
+41,300
| New | +$603K |
2016 Q3
0 quarters
|
|
|
CSTR
2325
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $590K | ﹤0.01% |
+34,803
| New | +$575K |
2016 Q3
0 quarters
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.